Table of Content

1 Biological Drugs Market Introduction and Overview
1.1 Biological Drugs Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Biological Drugs Revenue and Market Share by Manufacturer
2.2 Manufacturers Biological Drugs Area Served, Product Types
2.3 Biological Drugs Market Competitive Situation and Trends
2.3.1 Biological Drugs Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Bristol-Myers Squibb
3.1.1 Bristol-Myers Squibb Company Profile
3.1.2 Biological Drugs Product Overview
3.1.3 Bristol-Myers Squibb Biological Drugs Market Performance (2018-2023)
3.1.4 Bristol-Myers Squibb Business Overview
3.2 Eli Lilly
3.2.1 Eli Lilly Company Profile
3.2.2 Biological Drugs Product Overview
3.2.3 Eli Lilly Biological Drugs Market Performance (2018-2023)
3.2.4 Eli Lilly Business Overview
3.3 Takeda
3.3.1 Takeda Company Profile
3.3.2 Biological Drugs Product Overview
3.3.3 Takeda Biological Drugs Market Performance (2018-2023)
3.3.4 Takeda Business Overview
3.4 Pfizer
3.4.1 Pfizer Company Profile
3.4.2 Biological Drugs Product Overview
3.4.3 Pfizer Biological Drugs Market Performance (2018-2023)
3.4.4 Pfizer Business Overview
3.5 Amgen
3.5.1 Amgen Company Profile
3.5.2 Biological Drugs Product Overview
3.5.3 Amgen Biological Drugs Market Performance (2018-2023)
3.5.4 Amgen Business Overview
3.6 F. Hoffmann-La Roche
3.6.1 F. Hoffmann-La Roche Company Profile
3.6.2 Biological Drugs Product Overview
3.6.3 F. Hoffmann-La Roche Biological Drugs Market Performance (2018-2023)
3.6.4 F. Hoffmann-La Roche Business Overview
3.7 Johnson & Johnson
3.7.1 Johnson & Johnson Company Profile
3.7.2 Biological Drugs Product Overview
3.7.3 Johnson & Johnson Biological Drugs Market Performance (2018-2023)
3.7.4 Johnson & Johnson Business Overview
3.8 Merck
3.8.1 Merck Company Profile
3.8.2 Biological Drugs Product Overview
3.8.3 Merck Biological Drugs Market Performance (2018-2023)
3.8.4 Merck Business Overview
3.9 Abbott Laboratories
3.9.1 Abbott Laboratories Company Profile
3.9.2 Biological Drugs Product Overview
3.9.3 Abbott Laboratories Biological Drugs Market Performance (2018-2023)
3.9.4 Abbott Laboratories Business Overview
3.10 Baxter
3.10.1 Baxter Company Profile
3.10.2 Biological Drugs Product Overview
3.10.3 Baxter Biological Drugs Market Performance (2018-2023)
3.10.4 Baxter Business Overview
3.11 Novartis
3.11.1 Novartis Company Profile
3.11.2 Biological Drugs Product Overview
3.11.3 Novartis Biological Drugs Market Performance (2018-2023)
3.11.4 Novartis Business Overview
3.12 Biogen
3.12.1 Biogen Company Profile
3.12.2 Biological Drugs Product Overview
3.12.3 Biogen Biological Drugs Market Performance (2018-2023)
3.12.4 Biogen Business Overview
3.13 GlaxoSmithKline
3.13.1 GlaxoSmithKline Company Profile
3.13.2 Biological Drugs Product Overview
3.13.3 GlaxoSmithKline Biological Drugs Market Performance (2018-2023)
3.13.4 GlaxoSmithKline Business Overview
4 Global Biological Drugs Historical and Forecast Market Analysis by Type
4.1 Global Biological Drugs Revenue and Market Share by Type
4.2 Global Biological Drugs Revenue Market Forecast by Type (2023-2029)
5 Global Biological Drugs Historical and Forecast Market Analysis by Application
5.1 Global Biological Drugs Revenue Market Share by Application (2018-2023)
5.2 Biological Drugs Revenue Market Forecast by Application (2023-2029)
6 Global Market Growth Trends Analysis
6.1 Global Biological Drugs Market Size & Forecast (2018-2029)
6.2 Biological Drugs Growth Trends Analysis by Regions
6.2.1 Biological Drugs Market Size by Regions: 2018 VS 2023 VS 2029
6.2.2 Biological Drugs Historic Revenue Market Size by Regions (2018-2023)
6.2.3 Biological Drugs Forecasted Revenue Market Size by Regions (2023-2029)
7 North America
7.1 North America Biological Drugs Revenue Market Size & Forecast (2018-2029)
7.2 North America Biological Drugs Revenue, Gross and Gross Margin (2018-2023)
7.3 North America PEST Analysis
8 Europe
8.1 Europe Biological Drugs Revenue Market Size & Forecast (2018-2029)
8.2 Europe Biological Drugs Revenue, Gross and Gross Margin (2018-2023)
8.3 Europe PEST Analysis
9 China
9.1 China Biological Drugs Revenue Market Size & Forecast (2018-2029)
9.2 China Biological Drugs Revenue, Gross and Gross Margin (2018-2023)
9.3 China PEST Analysis
10 Japan
10.1 Japan Biological Drugs Revenue Market Size & Forecast (2018-2029)
10.2 Japan Biological Drugs Revenue, Gross and Gross Margin (2018-2023)
10.3 Japan PEST Analysis
11 Korea
11.1 Korea Biological Drugs Revenue Market Size & Forecast (2018-2029)
11.2 Korea Biological Drugs Revenue, Gross and Gross Margin (2018-2023)
11.3 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Biological Drugs Revenue Market Size & Forecast (2018-2029)
12.2 Southeast Asia Biological Drugs Revenue, Gross and Gross Margin (2018-2023)
12.3 Southeast Asia PEST Analysis
13 India
13.1 India Biological Drugs Revenue Market Size & Forecast (2018-2029)
13.2 India Biological Drugs Revenue, Gross and Gross Margin (2018-2023)
13.3 India PEST Analysis
14 South America
14.1 South America Biological Drugs Revenue Market Size & Forecast (2018-2029)
14.2 South America Biological Drugs Revenue, Gross and Gross Margin (2018-2023)
14.3 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Biological Drugs Revenue Market Size & Forecast (2018-2029)
15.2 Middle East & Africa Biological Drugs Revenue, Gross and Gross Margin (2018-2023)
15.3 Middle East & Africa PEST Analysis
16 Biological Drugs Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Biological Drugs Industrial Chain Analysis
17 Biological Drugs Industry Dynamic Analysis
17.1 Biological Drugs Market Trends Analysis
17.2 Biological Drugs Market Drivers Analysis
17.3 Biological Drugs Market Challenges Analysis
17.4 Biological Drugs Market Restraints Analysis